Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Underwater endoscopic mucosal resection for a colonic polyp located at the scar after endoscopic band ligation.

Kono Y, Katayama T, Miyahara K, Moritou Y, Higashi R, Kunihiro M, Nakagawa M.

Endoscopy. 2019 Jul;51(7):E181-E182. doi: 10.1055/a-0875-3266. Epub 2019 Apr 12. No abstract available.

PMID:
30978735
2.

The Progression of Esophageal Mucosa-associated Lymphoid Tissue Lymphoma after Helicobacter pylori Eradication Therapy: A Case Report and Discussion of Therapeutic Options.

Takeuchi Y, Miyahara K, Morito T, Okikawa Y, Kinugasa H, Moritou Y, Higashi R, Kunihiro M, Nakagawa M.

Intern Med. 2019 Jan 15;58(2):207-212. doi: 10.2169/internalmedicine.1112-18. Epub 2018 Aug 24.

3.

Dexmedetomidine for conscious sedation with colorectal endoscopic submucosal dissection: a prospective double-blind randomized controlled study.

Kinugasa H, Higashi R, Miyahara K, Moritou Y, Hirao K, Ogawa T, Kunihiro M, Nakagawa M.

Clin Transl Gastroenterol. 2018 Jul 4;9(7):167. doi: 10.1038/s41424-018-0032-5.

4.

Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.

Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, Fuse S, Hamaoka K, Hirono K, Kato T, Mitani Y, Sato S, Shimoyama S, Shiono J, Suda K, Suzuki H, Maeda J, Waki K; and The Z-score Project 2nd Stage Study Group, Kato H, Saji T, Yamagishi H, Ozeki A, Tomotsune M, Yoshida M, Akazawa Y, Aso K, Doi S, Fukasawa Y, Furuno K, Hayabuchi Y, Hayashi M, Honda T, Horita N, Ikeda K, Ishii M, Iwashima S, Kamada M, Kaneko M, Katyama H, Kawamura Y, Kitagawa A, Komori A, Kuraishi K, Masuda H, Matsuda S, Matsuzaki S, Mii S, Miyamoto T, Moritou Y, Motoki N, Nagumo K, Nakamura T, Nishihara E, Nomura Y, Ogata S, Ohashi H, Okumura K, Omori D, Sano T, Suganuma E, Takahashi T, Takatsuki S, Takeda A, Terai M, Toyono M, Watanabe K, Watanabe M, Yamamoto M, Yamamura K.

JAMA Pediatr. 2018 May 7;172(5):e180030. doi: 10.1001/jamapediatrics.2018.0030. Epub 2018 May 7.

5.

Management of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the MALT1 gene.

Iwamuro M, Takenaka R, Nakagawa M, Moritou Y, Saito S, Hori S, Inaba T, Kawai Y, Toyokawa T, Tanaka T, Yoshino T, Okada H.

World J Gastroenterol. 2017 Sep 7;23(33):6155-6163. doi: 10.3748/wjg.v23.i33.6155.

6.

Importance of Second-look Endoscopy on an Empty Stomach for Finding Gastric Bezoars in Patients with Gastric Ulcers.

Iwamuro M, Tanaka S, Moritou Y, Inaba T, Higashi R, Kusumoto C, Yunoki N, Ishikawa S, Okamoto Y, Kawai Y, Kitada KI, Takenaka R, Toyokawa T, Okada H.

Acta Med Okayama. 2017 Jun;71(3):241-247. doi: 10.18926/AMO/55207.

7.

Diospyrobezoar and a fondness for persimmons.

Matsuura H, Moritou Y, Kinoshita T, Asano Y, Mashima S, Hayashi K.

QJM. 2017 Jun 1;110(6):401-402. doi: 10.1093/qjmed/hcx039. No abstract available.

PMID:
28339942
8.

Gastric anisakiasis.

Matsuura H, Moritou Y.

QJM. 2017 Apr 1;110(4):251. doi: 10.1093/qjmed/hcx009. No abstract available.

PMID:
28062739
9.

Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development.

Takeuchi Y, Ikeda F, Osawa T, Araki Y, Takaguchi K, Morimoto Y, Hashimoto N, Sakaguchi K, Sakata T, Ando M, Makino Y, Matsumura S, Takayama H, Seki H, Nanba S, Moritou Y, Yasunaka T, Ohnishi H, Takaki A, Nouso K, Iwasaki Y, Yamamoto K.

World J Hepatol. 2015 Sep 8;7(19):2220-8. doi: 10.4254/wjh.v7.i19.2220.

10.

Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C.

Nanba S, Ikeda F, Baba N, Takaguchi K, Senoh T, Nagano T, Seki H, Takeuchi Y, Moritou Y, Yasunaka T, Ohnishi H, Miyake Y, Takaki A, Nouso K, Iwasaki Y, Yamamoto K.

J Clin Pathol. 2016 Mar;69(3):226-33. doi: 10.1136/jclinpath-2015-203215. Epub 2015 Aug 19.

PMID:
26290259
11.

Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis.

Seki H, Ikeda F, Nanba S, Moritou Y, Takeuchi Y, Yasunaka T, Onishi H, Miyake Y, Takaki A, Nouso K, Iwasaki Y, Nakamura M, Yamamoto K.

Acta Med Okayama. 2015;69(3):137-44.

12.

The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients.

Hiraoka S, Kato J, Moritou Y, Takei D, Inokuchi T, Nakarai A, Takahashi S, Harada K, Okada H, Yamamoto K.

BMC Gastroenterol. 2015 Apr 29;15:53. doi: 10.1186/s12876-015-0285-3.

13.

Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.

Nakarai A, Kato J, Hiraoka S, Inokuchi T, Takei D, Moritou Y, Akita M, Takahashi S, Hori K, Harada K, Okada H, Yamamoto K.

World J Gastroenterol. 2014 Dec 28;20(48):18367-74. doi: 10.3748/wjg.v20.i48.18367.

14.

Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor.

Moritou Y, Ikeda F, Iwasaki Y, Baba N, Takaguchi K, Senoh T, Nagano T, Takeuchi Y, Yasunaka T, Ohnishi H, Miyake Y, Takaki A, Nouso K, Yamamoto K.

Acta Med Okayama. 2014;68(1):17-22.

15.

Necessity for reassessment of patients with serogroup 2 hepatitis C virus (HCV) and undetectable serum HCV RNA.

Moritou Y, Ikeda F, Takeuchi Y, Seki H, Nanba S, Iwasaki Y, Yamamoto K.

J Clin Microbiol. 2014 Feb;52(2):544-8. doi: 10.1128/JCM.02792-13. Epub 2013 Dec 4.

16.

Effects of mosapride on esophageal motor activity and esophagogastric junction compliance in healthy volunteers.

Fukazawa K, Furuta K, Adachi K, Moritou Y, Saito T, Kusunoki R, Uno G, Shimura S, Aimi M, Ohara S, Ishihara S, Kinoshita Y.

J Gastroenterol. 2014 Sep;49(9):1307-13. doi: 10.1007/s00535-013-0876-0. Epub 2013 Sep 7.

PMID:
24013654
17.

Assessment of health-related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C.

Matsushita H, Ikeda F, Iwasaki Y, Seki H, Nanba S, Takeuchi Y, Moritou Y, Yasunaka T, Onishi H, Miyake Y, Takaki A, Nouso K, Yamamoto K.

J Gastroenterol Hepatol. 2014 Feb;29(2):337-43. doi: 10.1111/jgh.12337.

18.

Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C.

Moritou Y, Ikeda F, Iwasaki Y, Baba N, Takaguchi K, Senoh T, Nagano T, Takeuchi Y, Yasunaka T, Ohnishi H, Miyake Y, Takaki A, Nouso K, Yamamoto K.

Springerplus. 2013 Jun 1;2(1):251. doi: 10.1186/2193-1801-2-251. Print 2013 Dec.

19.

Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: a 5-year study of patients with hepatitis B with lamivudine resistance.

Ikeda F, Baba N, Takaguchi K, Kubota J, Miyoshi K, Fujioka S, Moritou Y, Takeuchi Y, Yasunaka T, Miyake Y, Takaki A, Iwasaki Y, Kobashi H, Yamamoto K.

J Med Virol. 2012 Oct;84(10):1562-70. doi: 10.1002/jmv.23371.

PMID:
22930504
20.

The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis.

Takeuchi Y, Ikeda F, Moritou Y, Hagihara H, Yasunaka T, Kuwaki K, Miyake Y, Ohnishi H, Nakamura S, Shiraha H, Takaki A, Iwasaki Y, Nouso K, Yamamoto K.

J Gastroenterol. 2013 Mar;48(3):405-12. doi: 10.1007/s00535-012-0647-3. Epub 2012 Aug 7.

21.

Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554.

Maezaki H, Banno Y, Miyamoto Y, Moritoh Y, Asakawa T, Kataoka O, Takeuchi K, Suzuki N, Ikedo K, Kosaka T, Sasaki M, Tsubotani S, Tani A, Funami M, Yamamoto Y, Tawada M, Aertgeerts K, Yano J, Oi S.

Bioorg Med Chem. 2011 Aug 1;19(15):4482-98. doi: 10.1016/j.bmc.2011.06.032. Epub 2011 Jul 7. Erratum in: Bioorg Med Chem. 2011 Sep 15;19(18):5742. Moritou, Yuusuke [corrected to Moritoh, Yusuke].

PMID:
21741847

Supplemental Content

Loading ...
Support Center